Atlas Capital Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-45
| Closed | -$4.16K | – | 927 |
|
|
2024
Q2 | $4.16K | Hold |
45
| – | – | ﹤0.01% | 791 |
|
|
2024
Q1 | $4.3K | Hold |
45
| – | – | ﹤0.01% | 773 |
|
|
2023
Q4 | $3.43K | Hold |
45
| – | – | ﹤0.01% | 804 |
|
|
2023
Q3 | $3.12K | Hold |
45
| – | – | ﹤0.01% | 785 |
|
|
2023
Q2 | $4.24K | Buy |
+45
| New | +$4.24K | ﹤0.01% | 793 |
|
|
2023
Q1 | – | Sell |
-45
| Closed | -$3.36K | – | 926 |
|
|
2022
Q4 | $3.36K | Hold |
45
| – | – | ﹤0.01% | 810 |
|
|
2022
Q3 | $3.72K | Hold |
45
| – | – | ﹤0.01% | 799 |
|
|
2022
Q2 | $4.28K | Hold |
45
| – | – | ﹤0.01% | 865 |
|
|
2022
Q1 | $5.3K | Hold |
45
| – | – | ﹤0.01% | 787 |
|
|
2021
Q4 | $5.83K | Hold |
45
| – | – | ﹤0.01% | 786 |
|
|
2021
Q3 | $5.09K | Hold |
45
| – | – | ﹤0.01% | 808 |
|
|
2021
Q2 | $4.66K | Buy |
+45
| New | +$4.66K | ﹤0.01% | 827 |
|